Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "global" return 68 results.
Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health >
Ceva and Touchlight entered into an agreement and a long-term collaboration for the development and manufacture of new dbDNA vaccines and therapeutics across a broad range of animal health indications...
Ceva Names New SVP for North America >
Brad McCollum will lead Ceva’s business in the United States and Canada.
WVA Global Veterinary Awards launched >
New awards recognize work in One Health, Animal Welfare, Medicine Stewardship and Veterinary Education
Ceva Launches Wildlife Research Fund >
Ceva Wildlife Research Fund, the first endowment fund dedicated to research to protect wildlife.
Program Receives Quality Recognition >
Ceva’s U.S. C.H.I.C.K Program receives independently audited quality recognition from Bureau Veritas
Ceva Returns Strong Double-Digit Growth in 2019; Plans to Double sales by 2020. >
Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019.
Ceva Helps to Expand COVID-19 Testing >
MAWD Pathology increases same-day COVID-19 testing using equipment on loan from Ceva
Ceva's Poultry Group Hosting New Technology Summit >
Ceva launches a “new wave of innovation” to help poultry producers meet the performance challenges driven by the need for “No antibiotics” and more sustainable production
Ceva sponsors 2017 Global Animal Welfare Awards. >
Awards will honor veterinarians who provide exemplary welfare-related services.
Ceva Santé Animale confirms its circle of virtuous growth in 2016 >
2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m.